Novo Nordisk
NVO
553 hedge funds and large institutions have $8.09B invested in Novo Nordisk in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 155 increasing their positions, 207 reducing their positions, and 53 closing their positions.
217% more call options, than puts
Call options by funds: $51.7M | Put options by funds: $16.3M
8% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 53
0% more funds holding
Funds holding: 552 → 553 (+1)
0.03% less ownership
Funds ownership: 16.76% → 16.73% (-0.03%)
8% less capital invested
Capital invested by funds: $8.83B → $8.09B (-$741M)
25% less repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 207
26% less funds holding in top 10
Funds holding in top 10: 19 → 14 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$71.4M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$69.5M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$34.5M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$22.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$21.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$61.9M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$57.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$17.6M |
| 5 |
RBCM
Raub Brock Capital Management
Larkspur,
California
|
-$17.5M |
NVO Hedge Fund Activity: Q1 2018 in Review
553 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2018, worth a combined $8.09B — down 8.4% from $8.83B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new NVO positions and 53 closed out — a net gain of 4 holders — while 155 added to existing stakes and 207 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $71.4M. The largest seller was Folketrygdfondet, cutting an estimated $61.9M.
- 553 institutional investors held Novo Nordisk (NVO) as of Q1 2018, up from 552 in Q4 2017.
- Funds reported $8.09B of Novo Nordisk stock for Q1 2018, down 8.4% quarter-over-quarter.
- 57 funds opened new Novo Nordisk positions in Q1 2018 and 53 closed out, a net change of +4 holders.
- The largest Novo Nordisk buyer in Q1 2018 was Renaissance Technologies, an estimated $71.4M added.
- The largest Novo Nordisk seller in Q1 2018 was Folketrygdfondet, an estimated $61.9M sold.
Based on aggregated 13F filings for Q1 2018.